Operating
Acquired in-process research and development
Over 3 years (FY 2021 to FY 2025), Acquired in-process research and development shows a downward trend with a -100.0% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
First reportedQ1 2019
Last reportedQ1 2026May 4, 2026
Metric ID:
operating_research_and_development_asset_acquired_other__65ec84Historical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $389.00M | $389.00M | $389.00M | $0.00 | $0.00 | $0.00 | $0.00 | $1.19B | $10.22B | $656.00M | $0.00 | $2.10B | $700.00M | $0.00 | $0.00 | $0.00 | $0.00 | $8.54B |
| QoQ Change | — | +0.0% | +0.0% | -100.0% | — | — | — | — | +757.1% | -93.6% | -100.0% | — | -66.7% | -100.0% | — | — | — | — |
| YoY Change | — | — | — | — | -100.0% | -100.0% | -100.0% | — | — | -45.0% | — | — | -93.1% | -100.0% | — | -100.0% | -100.0% | — |
Range$0.00 – $10.22B
CAGR+106.8%
Avg YoY Growth-92.3%
Median YoY Growth-100.0%
Acquired in-process research and development at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s acquired in-process research and development?
- Merck & Co. (MRK) reported acquired in-process research and development of $8.54B in Q1 2026.
- What is the long-term trend for Merck & Co.'s acquired in-process research and development?
- Over 3 years (2021 to 2025), Merck & Co.'s acquired in-process research and development has grown at a -100.0% compound annual growth rate (CAGR), from $1.56B to $0.00.